Arnold & Porter's merger control offering boasts experience supporting large, multinational clients such as AT&T, BP, Visa, Cisco and Samsung, who seek out the team for its in-depth knowledge of antitrust practice. Its expertise regarding the life sciences sector is particularly notable, paired with comprehensive antitrust experience across mergers, litigation, government investigations, and cartel matters. Debbie Feinstein and Michael B. Bernstein co-head the team from Washington DC: a former Director of the Bureau of Competition at the FTC, Feinstein focuses her practice on merger and acquisition reviews by enforcement agencies across the US and globally. Both public and private companies seek out Bernstein for their significant merger matters. Jonathan Gleklen is a go-to for clients in the high technology and network industries, and Sonia Pfaffenroth draws on longstanding experience in the Department of Justice to handle complex antitrust litigation: both are based in Washington DC. The team grew in November 2024 with the addition of William Efron, formerly of the Federal Trade Commission.
L'éditorial du Legal 500

Distinctions

La satisfaction du client: Qualité de l’avocat et de l’équipe
La satisfaction du client: Facturation et efficacité
La satisfaction du client: Connaissance du secteur
La satisfaction du client: NPS ®

Clients clés

  • AbbVie
  • Boston Scientific
  • BP
  • Bristol-Myers Squibb
  • Kroger
  • Onex
  • Pfizer
  • Recochem
  • Visa

Points forts

Assisted Pfizer in its US$43 billion acquisition of Seagen.
Representing Kroger as lead antitrust counsel in its US$24.6 billion proposed acquisition of the Albertsons companies and related divestiture to C&S Wholesale.
Represented AbbVie in its US$8.7 billion acquisition of Cerevel Therapeutics.
Responsable de la pratique

Debbie Feinstein; Michael B. Bernstein

Autres avocats clés

Matthew Tabas; David Emanuelson; William Efron; Sonia Pfaffenroth; Jonathan Gleklen